Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    National Health Investors...

    NYSE: NHI · Real-Time Price · USD
    74.31
    0.06 (0.08%)
    At close: Aug 15, 2025, 10:00 AM

    National Health Investors Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
    Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
    Revenue
    		 91.39M 89.3M 85.75M 82.94M 84.97M 81.51M 79.47M 80.11M 77.88M 82.39M 70.67M 76.3M 59.9M 71.33M 69.67M 73.83M 74.33M 80.89M
    Cost of Revenue
    		 33.95M 2.89M 2.84M 2.79M 2.8M 2.73M 2.77M 2.91M 3.21M 2.62M 2.23M 2.36M 2.16M 3.04M 4.12M 3.18M 2.17M 2.16M
    Gross Profit
    		 57.43M 86.41M 82.91M 80.16M 82.17M 78.78M 76.69M 77.2M 74.66M 79.77M 68.44M 73.94M 57.74M 68.29M 65.55M 70.65M 72.16M 78.72M
    Operating Income
    		 51.07M 47.88M 42.91M 46.51M 49.16M 45.27M 46.31M 202K 41.74M 46.81M 35.97M 42.11M 20.09M 14.97M 18.13M 24.18M 46.5M 49.62M
    Interest Income
    		 n/a n/a n/a n/a n/a n/a n/a 15.09M 14.19M 14.03M -616K n/a n/a n/a n/a n/a n/a n/a
    Pretax Income
    		 36.69M 33.82M 42.74M 28.24M 34.95M 30.66M 31.8M 29.03M 39.45M 34.18M 1.56M 34.23M 21.47M 8.25M 6.5M 30.85M 39.23M 35.38M
    Net Income
    		 36.99M 34.16M 43.24M 28.54M 35.26M 30.95M 32.05M 29.35M 39.78M 7.78M 1.86M 34.47M 11.21M -1.31M 6.48M 30.81M 39.18M 35.33M
    Selling & General & Admin
    		 6.13M 8.26M 5.83M 5.05M 5.04M 5.88M 5.07M 4.5M 4.48M 5.78M 5.18M 4.83M 5.39M 9.93M 3.9M 3.77M 3.55M 8.12M
    Research & Development
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Other Expenses
    		 n/a 30.28M 34.17M 28.59M 27.97M 27.63M 1.73M -1.76M -166K 27.6M 63.26M -11.33M 31.2M 43.04M 350K 42.7M 22.11M 20.99M
    Operating Expenses
    		 10.4M 38.53M 40M 33.65M 33.01M 33.51M 31.95M 32.06M 32.15M 33.37M 68.44M 31.83M 36.59M 52.97M 51.72M 46.47M 25.66M 29.11M
    Interest Expense
    		 n/a n/a 14.03M n/a 13.98M 14.05M n/a 14.37M 13.59M 14.03M 11.83M n/a n/a n/a 12.28M n/a n/a n/a
    Selling & Marketing Expenses
    		 n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
    Cost & Expenses
    		 40.32M 41.42M 42.84M 36.43M 35.81M 36.24M 34.72M 34.97M 35.36M 35.99M 70.67M 34.19M 38.75M 56.01M 55.84M 49.65M 27.83M 31.27M
    Income Tax Expense
    		 n/a n/a -45K n/a n/a n/a 16.17M 12.3M 13.09M 26.41M n/a n/a 10.25M 9.56M 11.65M 11.56M n/a n/a
    Shares Outstanding (Basic)
    		 46.69M 45.72M 45.12M 43.48M 43.4M 43.39M 43.39M 43.39M 43.39M 43.39M 43.39M 44.34M 45.71M 45.85M 45.85M 45.85M 45.85M 45.31M
    Shares Outstanding (Diluted)
    		 46.82M 45.88M 45.44M 43.99M 43.56M 43.42M 43.39M 43.39M 43.39M 43.39M 43.39M 44.4M 45.72M 45.85M 45.85M 45.85M 45.86M 45.36M
    EPS (Basic)
    		 0.79 0.75 0.96 0.66 0.81 0.71 0.74 0.68 0.92 0.18 0.04 0.78 0.25 -0.03 0.14 0.67 0.85 0.78
    EPS (Diluted)
    		 0.79 0.74 0.95 0.65 0.81 0.71 0.74 0.68 0.92 0.18 0.04 0.78 0.25 -0.03 0.14 0.67 0.85 0.78
    EBITDA
    		 71.71M 66.33M 75.45M 60.08M 66.42M 62.21M 63.42M 63.44M 59.47M 64.43M 30.69M 59.64M 37.86M 33.24M 31.51M 42.23M 65.03M 68.51M
    EBIT
    		 51.07M 47.18M 56.77M 42.31M 48.93M 44.7M 44.59M 45.21M 42.69M 46.52M 13.39M 45.03M 25.58M 17.14M 11.96M 22.45M 44.64M 47.97M
    Depreciation & Amortization
    		 20.64M 19.16M 18.68M 17.77M 17.49M 17.5M 17.83M 18.24M 18.51M 17.92M 17.3M 17.53M 24.94M 18.52M 19.55M 19.78M 20.4M 20.55M

    Add to Watchlist